immune signatures
Showing 1 - 25 of >10,000
iMmune SignAtures and Clinical outComes in AP
Recruiting
- Acute Pancreatitis
- CyTOF Analysis
-
Los Angeles, California
- +4 more
May 17, 2023
Profiling of Circulating Immune Cells to Uncover Response
Not yet recruiting
- Melanoma
- (no location specified)
Nov 23, 2023
TB - Tuberculosis, HIV/AIDS Trial in Cape Town
Recruiting
- TB - Tuberculosis
- HIV/AIDS
-
Cape Town, Western Cape, South Africa
- +2 more
May 30, 2022
Lung Trial in Charlotte (Biomarkers and ctDNA)
Recruiting
- Lung Cancer, Nonsmall Cell
- Blood and tissue samples
-
Charlotte, North CarolinaLevine Cancer Institute
Jan 17, 2023
Immune Fitness Prediction
Completed
- Healthy Adults
-
Lausanne, Vaud, SwitzerlandNestlé Clinical Research Unit
Feb 3, 2022
Pathogen-microbiome Interaction During Helicobacter Pylori
Recruiting
- Helicobacter Pylori Infection
- Analysis of gut microbiome and immune signatures
-
Freiburg, Baden Württemberg, GermanyInstitute for Microbiology and Hygiene
May 17, 2022
Immune Cell Signatures in Autoimmunity and Dry Eye Syndrome
Recruiting
- Autoimmunity
- Dry Eye Syndrome
- Cross-sectional study
-
Singapore, SingaporeCynthia Boo
Mar 22, 2022
Predict Risk of Kidney Transplant Rejection
Recruiting
- Kidney Transplant Rejection
-
Chicago, Illinois
- +14 more
Sep 9, 2022
Crohn Disease Trial in New York (Kono-S anastomosis (KSa), Side-to-side anastomosis (SSa))
Not yet recruiting
- Crohn Disease
- Kono-S anastomosis (KSa)
- Side-to-side anastomosis (SSa)
-
New York, New YorkWeill Cornell Medical Center
Nov 17, 2023
Atopic Dermatitis Trial in San Francisco (Dupilumab)
Recruiting
- Atopic Dermatitis
-
San Francisco, CaliforniaUniversity of California, San Francisco
May 4, 2023
Consequences of Poly Vaccination on Innate Immunity :
Not yet recruiting
- Vaccine Breakthrough Infections
- Blood and saliva sampling
- Survey
- (no location specified)
Oct 26, 2023
Psoriasis Vulgaris Trial in San Francisco (deucravacitinib)
Not yet recruiting
- Psoriasis Vulgaris
-
San Francisco, CaliforniaUniversity of California, San Francisco
May 4, 2023
Long COVID Trial in Angers (Blood sample (at inclusion and 6 months later), Patient questionnaires (at inclusion and 6 months
Not yet recruiting
- Long COVID
- Blood sample (at inclusion and 6 months later)
- Patient questionnaires (at inclusion and 6 months later)
-
Angers, FranceAngers University Hospital
Mar 8, 2023
Complex Regional Pain Syndromes Trial in Seoul
Recruiting
- Complex Regional Pain Syndromes
-
Seoul, Korea, Republic ofSeoul National University Hospital
Aug 3, 2023
Newborn Vaccine Immunogenicity Trial in Fajara, Goroka (Hepatitis B vaccine (HBV), Bacillus Calmette-Guérin (BCG))
Active, not recruiting
- Newborn Vaccine Immunogenicity
- Hepatitis B vaccine (HBV)
- Bacillus Calmette-Guérin (BCG)
-
Fajara, Gambia
- +1 more
Jan 12, 2023
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Los
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +5 more
- Anti-CD40 Agonist Monoclonal Antibody CDX-1140
- +3 more
-
Los Angeles, CaliforniaUSC/Norris Comprehensive Cancer Center
Jan 31, 2023
Multiple Sclerosis, Relapsing-Remitting Trial in Paris (50 ml blodd sampling)
Not yet recruiting
- Multiple Sclerosis, Relapsing-Remitting
- 50 ml blodd sampling
-
Paris, FranceHôpital La Pitié - Salpêtrière
Aug 16, 2022
Immune Function and the Progression to T1D
Recruiting
- Type 1 Diabetes
- blood draw
-
Gainesville, FloridaKieran McGrail
Jun 12, 2023
Local and Systemic Immunoprofiling of Patients Diagnosed With
Recruiting
- Ulcerative Colitis Flare
-
Nijmegen, Gelderland, NetherlandsRadboudUMC
Jan 10, 2023
Detect and Expunge Concealed Tumors of the Liver
Recruiting
- Liver Cancer
-
Hanoi, Vietnam108 Military Central Hospital
Nov 15, 2023
Glioblastoma, IDH-wildtype Trial in Rome (Biological biomarker analysis)
Not yet recruiting
- Glioblastoma, IDH-wildtype
- Biological biomarker analysis
-
Rome, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS
Jul 3, 2023
Immune Checkpoint Inhibitors in Non-Small Cell Lung Carcinoma
Active, not recruiting
- Non Small Cell Lung Cancer
- Immune signature in serum associated to the metabolic signature
- Meta-genomic signature of intestinal flora
-
La Tronche, Isère, FranceUniversity Hospital, Grenoble
Jan 6, 2023
Hepatocarcinoma, Pancreatic Tumor Trial in Clichy (Hepatocellular carcinoma, Pancreatic adenocarcinoma, Pancreatic
Recruiting
- Hepatocarcinoma
- Pancreatic Tumor
- Hepatocellular carcinoma
- +2 more
-
Clichy, FranceHôpital Beaujon
Mar 20, 2023
Host Blood RNA Signatures for Diagnosis of TB (RADIANT)
Recruiting
- Tuberculosis
- NanoString nCounter assay
-
Cape Town, Western Cape, South Africa
- +1 more
Sep 12, 2022
Signatures of Immune Reprogramming in Anti-CD52 Therapy of MS:
Unknown status
- Multiple Sclerosis
- Alemtuzumab Injection [Lemtrada]
-
Münster, NRW, GermanyDepartment of Neurology
Sep 18, 2019